demonstrated that melatonin inhibits hyperglyce-induced ferroptosis by activating the Nrf2/HO-1 signaling pathway in type 2 DOP, thereby delaying the onset of osteoporosis (89). The gene discussed is NFE2L2; the disease is osteoporosis.